We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Skip to main content
  • Register
  • My watchlists
  • Help
  • Contact us

Polarean Imaging Ltd (POLX) ORD GBP0.00037

Sell:46.00p Buy:47.00p 0 Change: No change
Market closed |  Prices as at close on 29 June 2022 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:46.00p
Buy:47.00p
Change: No change
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now
Market closed |  Prices as at close on 29 June 2022 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:46.00p
Buy:47.00p
Change: No change
Market closed |  Prices as at close on 29 June 2022 Prices delayed by at least 15 minutes | Switch to live prices |
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Polarean Imaging plc is a medical-imaging technology company. The Company with its subsidiaries operates in the medical imaging market and develops equipment to enable existing magnetic resonance imaging (MRI) systems. The Company develops equipment that enables existing MRI systems to attain an improved level of pulmonary function imaging and specializes in the use of hyperpolarised Xenon gas (129Xe) as an imaging agent to visualize ventilation. 129Xe gas is being studied for visualization of gas exchange regionally in the smallest airways of the lungs, across the alveolar tissue barrier, and into the pulmonary bloodstream. 129Xe used to evaluate pulmonary function and to visualize the lung using MRI. The Company operates in an area of unmet medical need and its technology provides an investigational diagnostic approach, offering a non-invasive and radiation-free functional imaging platform.

Contact details

Address:
2500 Meridian Pkwy Ste 175
DURHAM
27713-4214
United States
Telephone:
+1 (0919) 2067900
Website:
www.polarean.com/

Important dates

Future events
There are no future events available.
Past events
AGM 29 June 2022 29/06/22
Final results 18 May 2022 18/05/22
Interim results 02 September 2021 02/09/21
AGM 13 July 2021 13/07/21

General stock information

EPIC:
POLX
ISIN:
GB00BF3DT583
Market cap:
£98.78 million
Shares in issue:
212.44 million
Sector:
No specific Industry
Exchange:
London Stock Exchange
Currency:
Sterling pence
Indices:
n/a

Key personnel

  • Richard Hullihen
    Chief Executive Officer, Executive Director
  • Charles Osborne
    Chief Financial Officer, Executive Director
  • Bastiaan Driehuys
    Chief Technology Officer, Executive Director
  • Stephen Austin
    Company Secretary

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by NBTrader.
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now

Options

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.